Trilobatin ameliorates bone loss via suppression of osteoclast cell differentiation and bone resorptive function in vitro and in vivo

SC Kim, HJ Kim, GE Park, RP Pandey, J Lee, JK Sohng… - Life Sciences, 2021 - Elsevier
Aim Due to on-going safety concerns or lack of efficacy of currently used medications for the
treatment of osteoporosis (OP), identifying new therapeutic agents is an important part of …
被引用次数：7 相关文章

Trilobatin ameliorates bone loss via suppression of osteoclast cell differentiation and bone resorptive function in vitro and in vivo

SC Kim, HJ Kim, GE Park, RP Pandey, J Lee… - Life …, 2021 - pubmed.ncbi.nlm.nih.gov
Aim Due to on-going safety concerns or lack of efficacy of currently used medications for the
treatment of osteoporosis (OP), identifying new therapeutic agents is an important part of …

Trilobatin ameliorates bone loss via suppression of osteoclast cell differentiation and bone resorptive function in vitro and in vivo.

SC Kim, HJ Kim, GE Park, RP Pandey, J Lee, JK Sohng… - 2021 - cabidigitallibrary.org
Aim: Due to on-going safety concerns or lack of efficacy of currently used medications for the
treatment of osteoporosis (OP), identifying new therapeutic agents is an important part of …

Trilobatin ameliorates bone loss via suppression of osteoclast cell differentiation and bone resorptive function in vitro and in vivo

SC Kim, HJ Kim, GE Park, RP Pandey, J Lee… - Life …, 2021 - cuk.elsevierpure.com
Aim: Due to on-going safety concerns or lack of efficacy of currently used medications for the
treatment of osteoporosis (OP), identifying new therapeutic agents is an important part of …

Trilobatin ameliorates bone loss via suppression of osteoclast cell differentiation and bone resorptive function in vitro and in vivo.

SC Kim, HJ Kim, GE Park, RP Pandey, J Lee… - Life …, 2021 - europepmc.org
Aim Due to on-going safety concerns or lack of efficacy of currently used medications for the
treatment of osteoporosis (OP), identifying new therapeutic agents is an important part of …

[引用][C] Trilobatin ameliorates bone loss via suppression of osteoclast cell differentiation and bone resorptive function in vitro and in vivo

SC Kim, HJ Kim, GE Park, RP Pandey, J Lee, JK Sohng… - 2021